CN107519159A - 复方组合物 - Google Patents
复方组合物 Download PDFInfo
- Publication number
- CN107519159A CN107519159A CN201710623266.5A CN201710623266A CN107519159A CN 107519159 A CN107519159 A CN 107519159A CN 201710623266 A CN201710623266 A CN 201710623266A CN 107519159 A CN107519159 A CN 107519159A
- Authority
- CN
- China
- Prior art keywords
- ibuprofen
- acetaminophen
- combination
- composition
- dose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Dermatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Rheumatology (AREA)
- Anesthesiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NZ58901110 | 2010-11-04 | ||
| NZ589011 | 2010-11-04 | ||
| CN2011800525659A CN103298464A (zh) | 2010-11-04 | 2011-10-26 | 复方组合物 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2011800525659A Division CN103298464A (zh) | 2010-11-04 | 2011-10-26 | 复方组合物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN107519159A true CN107519159A (zh) | 2017-12-29 |
Family
ID=46024668
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710623266.5A Pending CN107519159A (zh) | 2010-11-04 | 2011-10-26 | 复方组合物 |
| CN2011800525659A Pending CN103298464A (zh) | 2010-11-04 | 2011-10-26 | 复方组合物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2011800525659A Pending CN103298464A (zh) | 2010-11-04 | 2011-10-26 | 复方组合物 |
Country Status (28)
| Country | Link |
|---|---|
| US (6) | US20130225685A1 (https=) |
| EP (1) | EP2635269B1 (https=) |
| JP (2) | JP2013541583A (https=) |
| KR (1) | KR101900520B1 (https=) |
| CN (2) | CN107519159A (https=) |
| AU (1) | AU2011324137B2 (https=) |
| BR (1) | BR112013010829B8 (https=) |
| CA (1) | CA2814057C (https=) |
| CL (1) | CL2013001250A1 (https=) |
| CO (1) | CO6771406A2 (https=) |
| CY (1) | CY1123398T1 (https=) |
| DK (1) | DK2635269T3 (https=) |
| ES (1) | ES2742373T3 (https=) |
| HR (1) | HRP20191489T1 (https=) |
| HU (1) | HUE045442T2 (https=) |
| LT (1) | LT2635269T (https=) |
| MX (2) | MX367209B (https=) |
| MY (1) | MY160572A (https=) |
| NZ (1) | NZ609727A (https=) |
| PH (2) | PH12013500689A1 (https=) |
| PL (1) | PL2635269T3 (https=) |
| PT (1) | PT2635269T (https=) |
| RS (1) | RS59258B1 (https=) |
| RU (2) | RU2707089C2 (https=) |
| SG (1) | SG189319A1 (https=) |
| SI (1) | SI2635269T1 (https=) |
| SM (1) | SMT201900481T1 (https=) |
| WO (1) | WO2012060719A1 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2707089C2 (ru) | 2010-11-04 | 2019-11-22 | АФТ Фармасьютикалз Лимитед | Комбинированная композиция |
| US9072710B2 (en) | 2012-03-16 | 2015-07-07 | Cumberland Pharmaceuticals Inc. | Injectable ibuprofen formulation |
| WO2016008546A1 (en) * | 2014-07-18 | 2016-01-21 | Everbright Pharmaceuticals S.A.R.L. | Aqueous formulation comprising paracetamol and ibuprofen |
| WO2016057389A1 (en) * | 2014-10-06 | 2016-04-14 | Cumberland Pharmaceuticals, Inc. | Co-administration of intravenous ibuprofen and acetaminophen for treatment of pain |
| WO2018192664A1 (en) | 2017-04-20 | 2018-10-25 | Hyloris Developments Sa | METHOD FOR PREPARING A COMPOSITION WITH A LOW DISSOLVED OXYGEN CONTENT, COMPRISING ACETAMINOPHEN, AND OPTIONALLY ONE OR MORE NSAIDs, AND A COMPOSITION OBTAINED THEREOF |
| NZ760633A (en) * | 2017-07-10 | 2025-11-28 | Gel Cap Tech Llc | Dual release dosage form capsule and methods, devices and systems for making same |
| US11197830B2 (en) | 2019-02-27 | 2021-12-14 | Aft Pharmaceuticals Limited | Pharmaceutical composition containing acetaminophen and ibuprofen |
| US11568752B2 (en) * | 2020-01-28 | 2023-01-31 | David Clark Company Incorporated | Gateway retrieval alert device for aircraft pushback operations |
| WO2023281089A2 (en) | 2021-07-08 | 2023-01-12 | Krka, D.D., Novo Mesto | Pharmaceutical composition comprising naproxen and paracetamol |
| GR1010769B (el) * | 2023-07-27 | 2024-09-18 | Ιουλια Κλεωνος Τσετη | Υδατικο διαλυμα ιβουπροφαινης για χρηση σε ενδοφλεβια χορηγηση |
| KR20260020463A (ko) | 2023-06-02 | 2026-02-11 | 이울리아 츠에티 | 이부프로펜을 포함하는 약학 조성물 |
| GR1010809B (el) * | 2023-09-13 | 2024-10-25 | Ιουλια Τσετη | Υδατικο διαλυμα ιβουπροφαινης παρακεταμολης για χρηση σε ενδοφλεβια χορηγηση |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101022789A (zh) * | 2004-07-07 | 2007-08-22 | Aft制药有限公司 | 一种药物组合物 |
| KR20080072839A (ko) * | 2005-10-13 | 2008-08-07 | 알코아 인코포레이티드 | 용융 알루미늄 고압 압출 장치 및 방법 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997020551A1 (en) * | 1995-12-05 | 1997-06-12 | Adcock Ingram Limited | Pharmaceutical composition comprising a skeletal muscle relaxant, a non-steroidal antiinflammatory agent and an analgesic |
| JP5185488B2 (ja) * | 2001-11-02 | 2013-04-17 | カンバーランド ファーマシューティカルズ，インコーポレーテッド | ２−（４−イソブチルフェニル）プロピオン酸の医薬組成物 |
| WO2004093864A1 (en) * | 2003-03-21 | 2004-11-04 | Mcneil-Ppc, Inc. | Non-steroidal anti-inflammatory drug dosing regimen |
| KR20060072839A (ko) * | 2004-12-23 | 2006-06-28 | 김경태 | 아세트아미노펜과 이부프로펜을 이용하여 통증조절과 해열작용을 하는 주사제 |
| ES2651444T3 (es) * | 2006-10-20 | 2018-01-26 | Johnson & Johnson Consumer Inc. | Combinación de acetaminofeno con ibuprofeno para el tratamiento del dolor |
| WO2008079818A2 (en) * | 2006-12-21 | 2008-07-03 | Soluprin Pharmaceuticals, Inc. | Intravenous administration of water soluble analgesic formulations |
| US20090264530A1 (en) * | 2008-04-16 | 2009-10-22 | Nickell Robert P | Combined nsaid and acetaminophen formulation and method |
| JP2012505830A (ja) * | 2008-10-14 | 2012-03-08 | エイエフティ ファーマスーティカルズ リミテッド | 医薬品及び医薬品治療 |
| AU2010224063B2 (en) * | 2009-03-12 | 2015-04-16 | Cumberland Pharmaceuticals Inc | Administration of intravenous ibuprofen |
| AU2011274652B2 (en) * | 2010-07-07 | 2013-08-15 | Aft Pharmaceuticals Limited | A combination composition comprising ibuprofen and paracetamol |
| RU2707089C2 (ru) | 2010-11-04 | 2019-11-22 | АФТ Фармасьютикалз Лимитед | Комбинированная композиция |
| WO2016057389A1 (en) * | 2014-10-06 | 2016-04-14 | Cumberland Pharmaceuticals, Inc. | Co-administration of intravenous ibuprofen and acetaminophen for treatment of pain |
-
2011
- 2011-10-26 RU RU2015103107A patent/RU2707089C2/ru active
- 2011-10-26 NZ NZ609727A patent/NZ609727A/en unknown
- 2011-10-26 SG SG2013026265A patent/SG189319A1/en unknown
- 2011-10-26 HU HUE11838295A patent/HUE045442T2/hu unknown
- 2011-10-26 MY MYPI2013001237A patent/MY160572A/en unknown
- 2011-10-26 PL PL11838295T patent/PL2635269T3/pl unknown
- 2011-10-26 ES ES11838295T patent/ES2742373T3/es active Active
- 2011-10-26 EP EP11838295.1A patent/EP2635269B1/en active Active
- 2011-10-26 CA CA2814057A patent/CA2814057C/en active Active
- 2011-10-26 BR BR112013010829A patent/BR112013010829B8/pt active IP Right Grant
- 2011-10-26 RS RSP20190963 patent/RS59258B1/sr unknown
- 2011-10-26 JP JP2013537631A patent/JP2013541583A/ja active Pending
- 2011-10-26 US US13/882,953 patent/US20130225685A1/en not_active Abandoned
- 2011-10-26 MX MX2015008709A patent/MX367209B/es unknown
- 2011-10-26 LT LTEP11838295.1T patent/LT2635269T/lt unknown
- 2011-10-26 KR KR1020137014178A patent/KR101900520B1/ko active Active
- 2011-10-26 PT PT11838295T patent/PT2635269T/pt unknown
- 2011-10-26 PH PH1/2013/500689A patent/PH12013500689A1/en unknown
- 2011-10-26 DK DK11838295.1T patent/DK2635269T3/da active
- 2011-10-26 SM SM20190481T patent/SMT201900481T1/it unknown
- 2011-10-26 WO PCT/NZ2011/000226 patent/WO2012060719A1/en not_active Ceased
- 2011-10-26 CN CN201710623266.5A patent/CN107519159A/zh active Pending
- 2011-10-26 RU RU2013123646/15A patent/RU2013123646A/ru not_active Application Discontinuation
- 2011-10-26 HR HRP20191489 patent/HRP20191489T1/hr unknown
- 2011-10-26 SI SI201131767T patent/SI2635269T1/sl unknown
- 2011-10-26 CN CN2011800525659A patent/CN103298464A/zh active Pending
- 2011-10-26 AU AU2011324137A patent/AU2011324137B2/en active Active
- 2011-10-26 MX MX2013005113A patent/MX2013005113A/es not_active Application Discontinuation
-
2013
- 2013-05-06 CL CL2013001250A patent/CL2013001250A1/es unknown
- 2013-05-22 CO CO13125952A patent/CO6771406A2/es not_active Application Discontinuation
-
2015
- 2015-08-21 US US14/832,154 patent/US20160235695A1/en not_active Abandoned
-
2017
- 2017-03-22 JP JP2017055893A patent/JP6353577B2/ja active Active
-
2018
- 2018-10-01 US US16/149,109 patent/US11446266B2/en active Active
-
2019
- 2019-07-18 CY CY20191100766T patent/CY1123398T1/el unknown
-
2021
- 2021-04-08 PH PH12021550804A patent/PH12021550804A1/en unknown
-
2022
- 2022-09-13 US US17/943,708 patent/US11896567B2/en active Active
-
2024
- 2024-01-05 US US18/405,907 patent/US12220392B2/en active Active
- 2024-12-30 US US19/005,738 patent/US20250134839A1/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101022789A (zh) * | 2004-07-07 | 2007-08-22 | Aft制药有限公司 | 一种药物组合物 |
| KR20080072839A (ko) * | 2005-10-13 | 2008-08-07 | 알코아 인코포레이티드 | 용융 알루미늄 고압 압출 장치 및 방법 |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12220392B2 (en) | Combination composition | |
| JP6381761B2 (ja) | 低減された投与容量を必要とする患者におけるベンダムスチン応答性症状の治療方法 | |
| US12042472B2 (en) | Sublingual epinephrine tablets | |
| AU2011274652B2 (en) | A combination composition comprising ibuprofen and paracetamol | |
| EP3393517B1 (en) | Acetylsalicylic acid for use in the treatment of moderate to severe influenza | |
| JP2022019937A (ja) | ヒト又は動物の慢性若しくは急性のウイルス感染症及び／又は敗血症の予防若しくは治療のための組成物 | |
| JP6856813B1 (ja) | 亜鉛点滴静注用製剤 | |
| WO2020155507A1 (zh) | 一种不含防腐剂的固体剂型氨己烯酸药物组合物 | |
| TW201434464A (zh) | 藥物 | |
| CN121868318A (zh) | 联合治疗乳腺癌骨转移的药物 | |
| JP2021161105A (ja) | ヒト又は動物の慢性若しくは急性のウイルス感染症及び／又は敗血症の予防若しくは治療のための組成物 | |
| CN107970248A (zh) | 异甘草酸在制备治疗高血压药物中的用途 | |
| HUP9902891A2 (hu) | Késleltetett kezdetű hányás kezelésére szolgáló metoklopranidtartalmú intranazális spray-készítmény |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20171229 |
|
| RJ01 | Rejection of invention patent application after publication |